Table 2.
IL‐6 | CRP | Troponin | nt‐proBNP | |
---|---|---|---|---|
Panel A | ||||
α1‐adr‐R‐Ab | 0.194 | 0.059 | 0.095 | −0.026 |
β1‐adr‐R‐Ab (cyc.) | 0.327* | 0.226* | 0.084 | −0.052 |
M5R‐Ab | 0.171 | 0.017 | 0.004 | 0.017 |
AT1R‐Ab | 0.174 | −0.000 | 0.043 | 0.013 |
AT2R‐Ab | 0.139 | −0.127 | −0.029 | 0.105 |
Panel B | ||||
α1‐adr‐R‐Ab | 0.053 | −0.034 | 0.070 | −0.021 |
β1‐adr‐R‐Ab (cyc.) | 0.184 | 0.116 | 0.185 | −0.094 |
M5R‐Ab | −0.009 | −0.164 | 0.076 | −0.003 |
AT1R‐Ab | 0.020 | −0.125 | 0.030 | −0.008 |
AT2R‐Ab | 0.054 | −0.198 | −0.014 | 0.095 |
Association of GPCR antibodies with IL‐6, CRP, troponin, and BNP within the heart failure group. Panel A: Native data. Panel B: Antibodies normalized to total IgG and logarithmized. Data given as Spearman rho with *P ≤ 0.05. n = 95–90.
CRP, C‐reactive protein; IL‐6, interleukin 6; nt‐proBNP, n‐terminal pro‐brain natriuretic peptide.